| The use of FISH on breast core needle samples for the presurgical assessment of HER-2 oncogene status. | |
| | |
MedLine Citation:
|
PMID: 12127055 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
HER-2 status has been used in breast carcinoma as a prognostic marker to predict drug response and to select patients for trastuzumab treatment. Since immunohistochemistry (IHC) is thought to be less reliable, HER-2 testing with FISH is preferred. The analysis of HER-2 is usually performed on formalin-fixed paraffin tissue sections obtained from surgery. The use of paraffin sections is very time consuming and labor intensive. The objectives of this study were to (1) develop a simple and quick FISH protocol using touch imprints of breast core needle biopsies, eliminating the deparaffinization and pretreatment; and (2) make the HER-2 status available at the presurgical multidisciplinary treatment planning conference. A total of 50 core samples of breast carcinoma were obtained from image-guided core needle biopsy. Both FISH and IHC data were available for 46 cases. Forty-four of 46 cases (95.7%) were consistent. Two IHC 2+ cases were nonamplified (ratios of 0.99 and 1.09). It is expected that, in the near future, additional molecular markers will be used before surgery when the overall treatment plan is being developed. We conclude that HER-2 gene analysis by FISH on breast touch imprints is easily done and is a useful and reliable technique. |
| | |
Authors:
|
Saori Kaneko; Tsilya Gerasimova; William M Butler; Tommy E Cupples; Paul L Guerry; Gwen R Greene; S Robert Young |
Related Documents
:
|
15125745 - Microtome shaving radiography: demonstration of loss of mammographic microcalcification... 17013595 - Guidelines from the european society of breast imaging for diagnostic interventional br... 19607725 - Development and validation of risk score for predicting positive repeat prostate biopsy... 20438405 - Clinicopathological features of prostate cancers detected after an initial diagnosis of... 11688845 - Review: significance of, and optimal screening for, her-2 gene amplification and protei... 12800215 - Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Experimental and molecular pathology Volume: 73 ISSN: 0014-4800 ISO Abbreviation: Exp. Mol. Pathol. Publication Date: 2002 Aug |
Date Detail:
|
Created Date: 2002-07-19 Completed Date: 2002-08-01 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370711 Medline TA: Exp Mol Pathol Country: United States |
Other Details:
|
Languages: eng Pagination: 61-6 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, University of South Carolina School of Medicine, Columbia 29203, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult African Continental Ancestry Group / genetics Aged Aged, 80 and over Biopsy, Needle Breast / pathology* Breast Neoplasms / genetics, pathology* Carcinoma, Ductal, Breast / genetics, pathology* Carcinoma, Intraductal, Noninfiltrating / genetics, pathology* Carcinoma, Lobular / genetics, pathology* European Continental Ancestry Group / genetics Female Gene Amplification Genes, erbB-2 / genetics* Humans Immunohistochemistry In Situ Hybridization, Fluorescence* Middle Aged Predictive Value of Tests Reproducibility of Results |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neoplastic reversal of human ovarian carcinoma cells transfected with connexin43.
Next Document: Ultrasonographic evidence of phenotypic instability during hepatocarcinogenesis in N-nitrosomorpholi...